Abstract Background Patients with metastatic Merkel cell carcinoma (mMCC) who experience disease progression on immunotherapy have limited additional standard options. Given evidence of synergism between radiation therapy (RT) and immunotherapy. two patients progressing on PD-1 inhibition were referred for short-course RT. Case presentation Two patients were found to have progressive ... https://pandaesfoxtoyes.shop/product-category/collections/